Skip to main content
Top
Published in: Journal of Translational Medicine 1/2016

Open Access 01-12-2016 | Research

Colorectal cancer-derived microvesicles modulate differentiation of human monocytes to macrophages

Authors: Monika Baj-Krzyworzeka, Bożenna Mytar, Rafał Szatanek, Marcin Surmiak, Kazimierz Węglarczyk, Jarek Baran, Maciej Siedlar

Published in: Journal of Translational Medicine | Issue 1/2016

Login to get access

Abstract

Background

Tumour-derived microvesicles (TMVs) are important players in tumour progression, modulating biological activity of immune cells e.g. lymphocytes, monocytes and macrophages. This phenomenon is particularly interesting in the progression of colon cancer, as macrophages in this type of tumour are relevant for the recovery processes. In the present study, the role of colon cancer cell-derived microvesicles in monocyte differentiation and activity profile (polarization) was investigated.

Methods

Monocyte-derived macrophages (MDM) were differentiated in vitro in the presence of TMVs obtained from colon cancer: Caco-2, SW620, LoVo or SW480 cell lines and analysed according to their morphology and biological functions, as defined by cytokine secretion, reactive oxygen intermediate (ROI) production and cytotoxic activity against respective colon cancer cells.

Results

Monocytes differentiated with TMVs exhibited morphological and phenotypical characteristics of macrophages. An early contact (beginning with the first day of the in vitro culture) of monocytes with TMVs resulted in increased IL-10 secretion and only slightly elevated TNF release. Early, or prolonged contact resulted in low ROI production and low cytotoxicity against tumour cells. On the other hand, late contact of MDM with TMVs, stimulated MDM to significant TNF and IL-12 secretion, ROI production and enhanced cytotoxicity against tumour cells in vitro. In addition, differences in MDM response to TMVs from different cell lines were observed (according to cytokine secretion, ROI production and cytotoxicity against tumour cells in vitro). Biological activity, STATs phosphorylation and microRNA profiling of MDMs indicated differences in their polarization/activation status which may suggest mixed polarization type M1/M2 with the predominance of proinflammatory cells after late contact with TMVs.

Conclusions

Macrophage activity (polarization status) may be regulated by contact with not only tumour cells but also with TMVs. Their final polarization status depends on the contact time, and probably on the vesicle “cargo”, as signified by the distinct impact of TMVs which enabled the switching of MDM maturation to regulatory macrophages.
Literature
1.
go back to reference Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet. 2005;14:153–65.CrossRef Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet. 2005;14:153–65.CrossRef
2.
go back to reference Swiderska M, Choromańska B, Dąbrowska E, Konarzewska-Duchnowska E, Choromańska K, Szczurko G, Myśliwiec P, Dadan J, Ladny JR, Zwierz K. The diagnostics of colorectal cancer. Contemp Oncol (Pozn). 2014;18:1–6. Swiderska M, Choromańska B, Dąbrowska E, Konarzewska-Duchnowska E, Choromańska K, Szczurko G, Myśliwiec P, Dadan J, Ladny JR, Zwierz K. The diagnostics of colorectal cancer. Contemp Oncol (Pozn). 2014;18:1–6.
4.
go back to reference Mantovani A, Germano G, Marchesi F, Locatelli M, Biswas SK. Cancer-promoting tumour-associated macrophages: new vistas and open questions. Eur J Immunol. 2011;41:2522–5.CrossRefPubMed Mantovani A, Germano G, Marchesi F, Locatelli M, Biswas SK. Cancer-promoting tumour-associated macrophages: new vistas and open questions. Eur J Immunol. 2011;41:2522–5.CrossRefPubMed
5.
go back to reference Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549–55.CrossRefPubMed Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549–55.CrossRefPubMed
6.
go back to reference Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71–8.CrossRefPubMed Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71–8.CrossRefPubMed
7.
go back to reference Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumour front correlates with improved survival in colon cancer. Clin Cancer Res. 2007;13:1472–9.CrossRefPubMed Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumour front correlates with improved survival in colon cancer. Clin Cancer Res. 2007;13:1472–9.CrossRefPubMed
8.
go back to reference Zhou Q, Peng RQ, Wu XJ, Xia Q, Hou JH, Ding Y, Zhou QM, Zhang X, Pang ZZ, Wan DS, Zeng YX, Zhang XS. The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med. 2010;8:13.PubMedCentralCrossRefPubMed Zhou Q, Peng RQ, Wu XJ, Xia Q, Hou JH, Ding Y, Zhou QM, Zhang X, Pang ZZ, Wan DS, Zeng YX, Zhang XS. The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med. 2010;8:13.PubMedCentralCrossRefPubMed
9.
go back to reference Ong SM, Tan SM, Beretta O, Jiang D, Yeap WH, Tai JJ, et al. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. Eur J Immunol. 2012;42:89–100.CrossRefPubMed Ong SM, Tan SM, Beretta O, Jiang D, Yeap WH, Tai JJ, et al. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. Eur J Immunol. 2012;42:89–100.CrossRefPubMed
10.
go back to reference Mantovani A, Locati M. Tumour-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol. 2013;33:1478–83.CrossRefPubMed Mantovani A, Locati M. Tumour-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol. 2013;33:1478–83.CrossRefPubMed
11.
go back to reference Antonyak MA, Cerione RA. Microvesicles as mediators of intercellular communication in cancer. Methods Mol Biol. 2014;1165:147–73.CrossRefPubMed Antonyak MA, Cerione RA. Microvesicles as mediators of intercellular communication in cancer. Methods Mol Biol. 2014;1165:147–73.CrossRefPubMed
12.
go back to reference Inal JM, Ansa-Addo EA, Stratton D, Kholia S, Antwi-Baffour SS, Jorfi S, Lange S. Microvesicles in health and disease. Arch Immunol Ther Exp (Warsz). 2012;60:107–21.CrossRef Inal JM, Ansa-Addo EA, Stratton D, Kholia S, Antwi-Baffour SS, Jorfi S, Lange S. Microvesicles in health and disease. Arch Immunol Ther Exp (Warsz). 2012;60:107–21.CrossRef
13.
go back to reference Lee TH, D’Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J. Microvesicles as mediators of intercellular communication in cancer–the emerging science of cellular ‘debris’. Semin Immunopathol. 2011;33:455–67.CrossRefPubMed Lee TH, D’Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J. Microvesicles as mediators of intercellular communication in cancer–the emerging science of cellular ‘debris’. Semin Immunopathol. 2011;33:455–67.CrossRefPubMed
14.
go back to reference Ratajczak J, Wysoczyński M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communications. Leukemia. 2006;20:1487–95.CrossRefPubMed Ratajczak J, Wysoczyński M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communications. Leukemia. 2006;20:1487–95.CrossRefPubMed
15.
go back to reference Rak J. Microparticles in cancer. Semin Thromb Hemostasis. 2010;36:888–906.CrossRef Rak J. Microparticles in cancer. Semin Thromb Hemostasis. 2010;36:888–906.CrossRef
16.
go back to reference Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–79.PubMed Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–79.PubMed
17.
go back to reference Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Zembala M. Tumour - derived microvesicles modulate biological activity of human monocytes. Immunol Lett. 2007;113:76–82.CrossRefPubMed Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Zembala M. Tumour - derived microvesicles modulate biological activity of human monocytes. Immunol Lett. 2007;113:76–82.CrossRefPubMed
18.
go back to reference Eigsti RL, Sudan B, Wilson ME, Graff JW. Regulation of activation-associated microRNA accumulation rates during monocyte-to-macrophage differentiation. J Biol Chem. 2014;289:28433–47.PubMedCentralCrossRefPubMed Eigsti RL, Sudan B, Wilson ME, Graff JW. Regulation of activation-associated microRNA accumulation rates during monocyte-to-macrophage differentiation. J Biol Chem. 2014;289:28433–47.PubMedCentralCrossRefPubMed
19.
go back to reference Mytar B, Siedlar M, Woloszyn M, Colizzi V, Zembala M. Cross-talk between human monocytes and cancer cells during reactive oxygen intermediates generation: the essential role of hyaluronan. Int J Cancer. 2001;94:727–32.CrossRefPubMed Mytar B, Siedlar M, Woloszyn M, Colizzi V, Zembala M. Cross-talk between human monocytes and cancer cells during reactive oxygen intermediates generation: the essential role of hyaluronan. Int J Cancer. 2001;94:727–32.CrossRefPubMed
20.
go back to reference Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Brański P, Ratajczak MZ, Zembala M. Tumour-derived microvesicles carry serveral surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother. 2006;55:808–18.CrossRefPubMed Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Brański P, Ratajczak MZ, Zembala M. Tumour-derived microvesicles carry serveral surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother. 2006;55:808–18.CrossRefPubMed
21.
go back to reference Mia S, Warnecke A, Zhang XM, Malmström V, Harris RA. Optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGFβ yields a dominant immunosuppressive phenotype. Scand J Immunol. 2014;79:305–14.PubMedCentralCrossRefPubMed Mia S, Warnecke A, Zhang XM, Malmström V, Harris RA. Optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGFβ yields a dominant immunosuppressive phenotype. Scand J Immunol. 2014;79:305–14.PubMedCentralCrossRefPubMed
22.
go back to reference Mytar B, Wołoszyn M, Szatanek R, Baj-Krzyworzeka M, Siedlar M, Ruggiero I, Więckiewicz J, Zembala M. Tumour cell-induced deactivation of human monocytes. J Leukoc Biol. 2003;74:1094–101.CrossRefPubMed Mytar B, Wołoszyn M, Szatanek R, Baj-Krzyworzeka M, Siedlar M, Ruggiero I, Więckiewicz J, Zembala M. Tumour cell-induced deactivation of human monocytes. J Leukoc Biol. 2003;74:1094–101.CrossRefPubMed
23.
go back to reference Xiang X, Poliakov A, Liu C, Liu Y, Deng ZB, Wang J, Cheng Z, Shah SV, Wang GJ, Zhang L, Grizzle WE, Mobley J, Zhang HG. Induction of myeloid-derived suppressor cells by tumour exosomes. Int J Cancer. 2009;124:2621–33.PubMedCentralCrossRefPubMed Xiang X, Poliakov A, Liu C, Liu Y, Deng ZB, Wang J, Cheng Z, Shah SV, Wang GJ, Zhang L, Grizzle WE, Mobley J, Zhang HG. Induction of myeloid-derived suppressor cells by tumour exosomes. Int J Cancer. 2009;124:2621–33.PubMedCentralCrossRefPubMed
24.
go back to reference Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G. Rivoltini L Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 2006;66:9290–8.CrossRefPubMed Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G. Rivoltini L Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 2006;66:9290–8.CrossRefPubMed
25.
go back to reference Lenart M, Rutkowska-Zapała M, Baj-Krzyworzeka M, Szatanek R, Węglarczyk K, Smallie T, Ziegler-Heitbrock L, Zembala M, Siedlar M. Hyaluronan carried by tumor-derived microvesicles induces IL-10 production in classical (CD14 ++CD16-) monocytes via PI3 K/Akt/mTOR-dependent signalling pathway. Immunobiology. 2015. doi:10.1016/j.imbio.2015.06.019 (pii: S0171–2985(15)30018-8).PubMed Lenart M, Rutkowska-Zapała M, Baj-Krzyworzeka M, Szatanek R, Węglarczyk K, Smallie T, Ziegler-Heitbrock L, Zembala M, Siedlar M. Hyaluronan carried by tumor-derived microvesicles induces IL-10 production in classical (CD14 ++CD16-) monocytes via PI3 K/Akt/mTOR-dependent signalling pathway. Immunobiology. 2015. doi:10.​1016/​j.​imbio.​2015.​06.​019 (pii: S0171–2985(15)30018-8).PubMed
26.
go back to reference Beyer M, Mallmann MR, Xue J, Staratschek-Jox A, Vorholt D, Krebs W, Sommer D, Sander J, Mertens C, Nino-Castro A, Schmidt SV, Schultze JL. High-resolution transcriptome of human macrophages. PLoS One. 2012;7:e.45466.CrossRef Beyer M, Mallmann MR, Xue J, Staratschek-Jox A, Vorholt D, Krebs W, Sommer D, Sander J, Mertens C, Nino-Castro A, Schmidt SV, Schultze JL. High-resolution transcriptome of human macrophages. PLoS One. 2012;7:e.45466.CrossRef
27.
go back to reference Wang B, Li Q, Qin L, Zhao S, Wang J, Chen X. Transition of tumour-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumour progression in mice. BMC Immunol. 2011;4(12):43.CrossRef Wang B, Li Q, Qin L, Zhao S, Wang J, Chen X. Transition of tumour-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumour progression in mice. BMC Immunol. 2011;4(12):43.CrossRef
28.
go back to reference Biswas SK, Allavena P, Mantovani A. Tumour-associated macrophages:functional diversity, clinical significance and open questions. Semin Immunopathol. 2013;35:585–600.CrossRefPubMed Biswas SK, Allavena P, Mantovani A. Tumour-associated macrophages:functional diversity, clinical significance and open questions. Semin Immunopathol. 2013;35:585–600.CrossRefPubMed
29.
go back to reference Ohtani H. Focus on TILs: prognostic significance of tumour infiltrating lymphocytes in human colorectal cancer. Cancer Immun. 2007;21(7):4. Ohtani H. Focus on TILs: prognostic significance of tumour infiltrating lymphocytes in human colorectal cancer. Cancer Immun. 2007;21(7):4.
30.
go back to reference Ohtani H, Naito Y, Saito K, Nagura H. Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: a possible antitumour immunity? Lab Invest. 1997;77:231–41.PubMed Ohtani H, Naito Y, Saito K, Nagura H. Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: a possible antitumour immunity? Lab Invest. 1997;77:231–41.PubMed
31.
go back to reference Squadrito ML, De Palma M. Macrophage regulation of tumour angiogenesis: implications for cancer therapy. Mol Aspects Med. 2011;32:123–45.CrossRefPubMed Squadrito ML, De Palma M. Macrophage regulation of tumour angiogenesis: implications for cancer therapy. Mol Aspects Med. 2011;32:123–45.CrossRefPubMed
32.
go back to reference Lewis CE. PollardJW. Distinct role of macrophages in different tumour microenvironments. Cancer Res. 2006;66:605–12.CrossRefPubMed Lewis CE. PollardJW. Distinct role of macrophages in different tumour microenvironments. Cancer Res. 2006;66:605–12.CrossRefPubMed
33.
go back to reference Van Overmeire E, Laoui D, Keirsse J, Van Ginderachter JA, Sarukhan A. Mechanisms driving macrophage diversity and specialization in distinct tumour microenvironments and parallelisms with other tissues. Front Immunol. 2014;26(5):127. Van Overmeire E, Laoui D, Keirsse J, Van Ginderachter JA, Sarukhan A. Mechanisms driving macrophage diversity and specialization in distinct tumour microenvironments and parallelisms with other tissues. Front Immunol. 2014;26(5):127.
34.
go back to reference Kinouchi M, Miura K, Mizoi T, Ishida K, Fujibuchi W, Sasaki H, Ohnuma S, Saito K, Katayose Y, Naitoh T, Motoi F, Shiiba K, Egawa S, Shibata C, Unno M. Infiltration of CD40-positive tumour-associated macrophages indicates a favorable prognosis in colorectal cancer patients. Hepatogastroenterology. 2013;60:83–8.PubMed Kinouchi M, Miura K, Mizoi T, Ishida K, Fujibuchi W, Sasaki H, Ohnuma S, Saito K, Katayose Y, Naitoh T, Motoi F, Shiiba K, Egawa S, Shibata C, Unno M. Infiltration of CD40-positive tumour-associated macrophages indicates a favorable prognosis in colorectal cancer patients. Hepatogastroenterology. 2013;60:83–8.PubMed
35.
go back to reference Tedesco S, Bolego C, Toniolo A, Nassi A, Fadini GP, Locati M, Cignarella A. Phenotypic activation and pharmacological outcomes of spontaneously differentiated human monocyte-derived macrophages. Immunobiology. 2014;220:545–54 (pii: S0171-2985(14)00277-0).CrossRefPubMed Tedesco S, Bolego C, Toniolo A, Nassi A, Fadini GP, Locati M, Cignarella A. Phenotypic activation and pharmacological outcomes of spontaneously differentiated human monocyte-derived macrophages. Immunobiology. 2014;220:545–54 (pii: S0171-2985(14)00277-0).CrossRefPubMed
36.
go back to reference Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L, De Palma M. miR-511-3p modulates genetic programs of tumour-associated macrophages. J Immunol. 2012;161:6250–7. Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L, De Palma M. miR-511-3p modulates genetic programs of tumour-associated macrophages. J Immunol. 2012;161:6250–7.
38.
go back to reference Rovida E, Paccagnini A, Del Rosso M, Peschon J. Dello Sbarba P. TNF-alpha converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J Immunol. 2001;166:1583–9.CrossRefPubMed Rovida E, Paccagnini A, Del Rosso M, Peschon J. Dello Sbarba P. TNF-alpha converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J Immunol. 2001;166:1583–9.CrossRefPubMed
39.
go back to reference Kuang DM, Wu Y, Chen N, Cheng J, Zhuang SM, Zheng L. Tumour-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood. 2007;110:587–95.CrossRefPubMed Kuang DM, Wu Y, Chen N, Cheng J, Zhuang SM, Zheng L. Tumour-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood. 2007;110:587–95.CrossRefPubMed
40.
go back to reference Graff JW, Dickson AM, Clay G, McCaffrey AP, Wilson ME. Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem. 2012;287:21816–25.PubMedCentralCrossRefPubMed Graff JW, Dickson AM, Clay G, McCaffrey AP, Wilson ME. Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem. 2012;287:21816–25.PubMedCentralCrossRefPubMed
41.
go back to reference Brase JC, Wuttig D, Kuner R, Sultmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer. 2010;26:306.CrossRef Brase JC, Wuttig D, Kuner R, Sultmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer. 2010;26:306.CrossRef
42.
go back to reference Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008;3:e3694.PubMedCentralCrossRefPubMed Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008;3:e3694.PubMedCentralCrossRefPubMed
43.
go back to reference Squadrito ML, Etzrodt M, De Palma M, Pittet MJ. MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol. 2013;34:350–9.PubMedCentralCrossRefPubMed Squadrito ML, Etzrodt M, De Palma M, Pittet MJ. MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol. 2013;34:350–9.PubMedCentralCrossRefPubMed
44.
go back to reference Ismail N, Wang Y, Dakhlalah D, Moldovan L, Agarwal K, Batte K, Shah P, Wisler J, Euband TD, Tridandapani S, Paulaitis E, Piper MG, Marsh CB. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 2013;121:984–95.PubMedCentralCrossRefPubMed Ismail N, Wang Y, Dakhlalah D, Moldovan L, Agarwal K, Batte K, Shah P, Wisler J, Euband TD, Tridandapani S, Paulaitis E, Piper MG, Marsh CB. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 2013;121:984–95.PubMedCentralCrossRefPubMed
45.
go back to reference Dumont P, Berton A, Nagy N. SandrasF, Tinton S, Demetter P, Mascart F, Allaoui A, Decaestecker C, Salmon I. Expression of galectin-3 in the tumour immune response in colon cancer. Lab Invest. 2008;88:896–906.CrossRefPubMed Dumont P, Berton A, Nagy N. SandrasF, Tinton S, Demetter P, Mascart F, Allaoui A, Decaestecker C, Salmon I. Expression of galectin-3 in the tumour immune response in colon cancer. Lab Invest. 2008;88:896–906.CrossRefPubMed
46.
go back to reference Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev BR, Min WP, Tullis RH. Exosomes as a tumour immune escape mechanism: possible therapeutic implications. J Transl Med. 2008;6:37.PubMedCentralCrossRefPubMed Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev BR, Min WP, Tullis RH. Exosomes as a tumour immune escape mechanism: possible therapeutic implications. J Transl Med. 2008;6:37.PubMedCentralCrossRefPubMed
47.
go back to reference Dai S, Wei B, Wu Z, Zhou X, Wei X, Huang H, Li G. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16:782–90.CrossRefPubMed Dai S, Wei B, Wu Z, Zhou X, Wei X, Huang H, Li G. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16:782–90.CrossRefPubMed
Metadata
Title
Colorectal cancer-derived microvesicles modulate differentiation of human monocytes to macrophages
Authors
Monika Baj-Krzyworzeka
Bożenna Mytar
Rafał Szatanek
Marcin Surmiak
Kazimierz Węglarczyk
Jarek Baran
Maciej Siedlar
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2016
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-016-0789-9

Other articles of this Issue 1/2016

Journal of Translational Medicine 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.